< 0 1 0 1 O
85 2 4 2 4 B-upper_bound
( 5 6 5 6 O
less 6 10 6 10 O
than 11 15 11 15 O
or 16 18 16 18 O
equal 19 24 19 24 O
to 25 27 25 27 O
85 28 30 28 30 B-upper_bound
years 31 36 31 36 I-upper_bound
at 37 39 37 39 O
the 40 43 40 43 O
time 44 48 44 48 O
of 49 51 49 51 O
signing 52 59 52 59 O
the 60 63 60 63 O
Informed 64 72 64 72 O
Consent 73 80 73 80 O
Form 81 85 81 85 O

Advanced 0 8 86 94 B-chronic_disease
pulmonary 9 18 95 104 I-chronic_disease
disease 19 26 105 112 I-chronic_disease

Apple 0 5 113 118 O
shaped 6 12 119 125 O
adiposity 13 22 126 135 B-chronic_disease

Be 0 2 136 138 O
a 3 4 139 140 O
female 5 11 141 147 B-gender
who 12 15 148 151 O
is 16 18 152 154 O
pregnant 19 27 155 163 B-pregnancy

Be 0 2 164 166 O
an 3 5 167 169 O
organ 6 11 170 175 B-treatment
transplant 12 22 176 186 I-treatment
recipient 23 32 187 196 O

Be 0 2 197 199 O
serum 3 8 200 205 O
positive 9 17 206 214 O
for 18 21 215 218 O
HIV 22 25 219 222 B-chronic_disease

Elevated 0 8 223 231 B-chronic_disease
triglycerides 9 22 232 245 I-chronic_disease

Female 0 6 246 252 B-gender
subjects 7 15 253 261 I-gender
must 16 20 262 266 O
undergo 21 28 267 274 O
a 29 30 275 276 O
blood 31 36 277 282 B-pregnancy
or 37 39 283 285 I-pregnancy
urine 40 45 286 291 I-pregnancy
pregnancy 46 55 292 301 I-pregnancy
test 56 60 302 306 O
at 61 63 307 309 O
screening 64 73 310 319 O
and 74 77 320 323 O
within 78 84 324 330 O
36 85 87 331 333 B-upper_bound
hours 88 93 334 339 I-upper_bound
prior 94 99 340 345 I-upper_bound
to 100 102 346 348 O
infusion 103 111 349 357 O

GFR 0 3 358 361 B-clinical_variable
< 4 5 362 363 O
or 6 8 364 366 O
equal 9 14 367 372 O
to 15 17 373 375 O
35 18 20 376 378 B-upper_bound

Have 0 4 379 383 O
a 5 6 384 385 O
clinical 7 15 386 394 O
history 16 23 395 402 O
of 24 26 403 405 O
malignancy 27 37 406 416 B-cancer
within 38 44 417 423 O
3 45 46 424 425 B-upper_bound
years 47 52 426 431 I-upper_bound

Have 0 4 432 436 O
a 5 6 437 438 O
history 7 14 439 446 O
of 15 17 447 449 O
drug 18 22 450 454 O
or 23 25 455 457 O
alcohol 26 33 458 465 O
abuse 34 39 466 471 O
within 40 46 472 478 O
the 47 50 479 482 O
past 51 55 483 487 B-upper_bound
24 56 58 488 490 I-upper_bound
months 59 65 491 497 I-upper_bound

Have 0 4 498 502 O
known 5 10 503 508 O
allergies 11 20 509 518 O
to 21 23 519 521 O
penicillin 24 34 522 532 B-allergy_name
or 35 37 533 535 O
streptomycin 38 50 536 548 B-allergy_name

Hemoglobin 0 10 549 559 B-clinical_variable
A1C 11 14 560 563 I-clinical_variable
greater 15 22 564 571 O
than 23 27 572 576 O
7 28 29 577 578 B-lower_bound

Hypersensitivity 0 16 579 595 O
to 17 19 596 598 O
dimethyl 20 28 599 607 B-allergy_name
sulfoxide 29 38 608 617 I-allergy_name
( 39 40 618 619 I-allergy_name
DMSO 40 44 619 623 I-allergy_name
) 44 45 623 624 I-allergy_name

Liver 0 5 625 630 B-chronic_disease
disease 6 13 631 638 I-chronic_disease

Proliferative 0 13 639 652 B-chronic_disease
diabetic 14 22 653 661 I-chronic_disease
retinopathy 23 34 662 673 I-chronic_disease

chronic 0 7 674 681 B-chronic_disease
kidney 8 14 682 688 I-chronic_disease
disease 15 22 689 696 I-chronic_disease
stage 23 28 697 702 B-lower_bound
3 29 30 703 704 I-lower_bound
or 31 33 705 707 O
higher 34 40 708 714 O

curatively- 0 11 715 726 O
treated 12 19 727 734 O
basal 20 25 735 740 B-cancer
cell 26 30 741 745 I-cancer
carcinoma 31 40 746 755 I-cancer

heart 0 5 756 761 B-chronic_disease
failure 6 13 762 769 I-chronic_disease
patients 14 22 770 778 O

hepatitis 0 9 779 788 B-chronic_disease
BsAg 10 14 789 793 I-chronic_disease
or 15 17 794 796 O
Viremic 18 25 797 804 B-chronic_disease
hepatitis 26 35 805 814 I-chronic_disease
C 36 37 815 816 I-chronic_disease

less 0 4 817 821 O
than 5 9 822 826 O
1 10 11 827 828 B-upper_bound
expected 12 20 829 837 O
life 21 25 838 842 B-clinical_variable
span 26 30 843 847 I-clinical_variable

melanoma 0 8 848 856 B-cancer
in 9 11 857 859 I-cancer
situ 12 16 860 864 I-cancer
or 17 19 865 867 O
cervical 20 28 868 876 B-cancer
carcinoma 29 38 877 886 I-cancer

participated 0 12 887 899 O
within 13 19 900 906 O
the 20 23 907 910 O
previous 24 32 911 919 B-upper_bound
30 33 35 920 922 I-upper_bound
days 36 40 923 927 I-upper_bound

squamous 0 8 928 936 B-cancer
cell 9 13 937 941 I-cancer
carcinoma 14 23 942 951 I-cancer

subjects 0 8 952 960 O
with 9 13 961 965 O
prior 14 19 966 971 B-cancer
malignancy 20 30 972 982 I-cancer
must 31 35 983 987 O
be 36 38 988 990 O
disease 39 46 991 998 O
free 47 51 999 1003 O
for 52 55 1004 1007 O
3 56 57 1008 1009 O
years 58 63 1010 1015 O

